Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 04/2/13 → 08/2/19 |
Funding
- Novartis Pharmaceuticals Corporation: $83,364.06
A 12-month, randomized, rater & dose-blinded study to compare efficacy & safety of fingolimod administered orally once daily with glatiramer acetate 20 mg administered subcutaneously once daily in patients with relapsing multiple sclerosis
- Coyle, Patricia K (PI)
- Kowalska, Agnieszka (CoPI)
- Sibony, Patrick (CoPI)
- Vlay, Stephen (CoPI)
Project: Research